Drug price history · CMS NADAC read 11 November 2026
Generic
$0.023 per unit at the 2013 year-end survey (25 NDCs) and $0.036 at the 2026 survey (17 NDCs): +57%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.023 | 25 | |
| 2014 (2014-12-31) | $0.023 | 27 | |
| 2015 (2015-12-30) | $0.021 | 23 | |
| 2016 (2016-12-28) | $0.024 | 24 | |
| 2017 (2017-12-27) | $0.020 | 24 | |
| 2018 (2018-12-26) | $0.029 | 21 | |
| 2019 (2019-12-25) | $0.033 | 16 | |
| 2020 (2020-12-30) | $0.038 | 12 | |
| 2021 (2021-12-29) | $0.038 | 14 | |
| 2022 (2022-12-28) | $0.038 | 15 | |
| 2023 (2023-12-27) | $0.045 | 12 | |
| 2024 (2024-12-25) | $0.038 | 15 | |
| 2025 (2025-12-31) | $0.042 | 15 | |
| 2026 (2026-11-11) | $0.036 | 17 |
Generic
$0.025 per unit at the 2013 year-end survey (25 NDCs) and $0.037 at the 2026 survey (17 NDCs): +47%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.025 | 25 | |
| 2014 (2014-12-31) | $0.026 | 28 | |
| 2015 (2015-12-30) | $0.024 | 23 | |
| 2016 (2016-12-28) | $0.024 | 24 | |
| 2017 (2017-12-27) | $0.021 | 24 | |
| 2018 (2018-12-26) | $0.041 | 21 | |
| 2019 (2019-12-25) | $0.040 | 14 | |
| 2020 (2020-12-30) | $0.038 | 12 | |
| 2021 (2021-12-29) | $0.040 | 12 | |
| 2022 (2022-12-28) | $0.042 | 18 | |
| 2023 (2023-12-27) | $0.052 | 13 | |
| 2024 (2024-12-25) | $0.042 | 16 | |
| 2025 (2025-12-31) | $0.047 | 17 | |
| 2026 (2026-11-11) | $0.037 | 17 |
Generic
$0.049 per unit at the 2013 year-end survey (24 NDCs) and $0.074 at the 2026 survey (16 NDCs): +49%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.049 | 24 | |
| 2014 (2014-12-31) | $0.046 | 27 | |
| 2015 (2015-12-30) | $0.047 | 24 | |
| 2016 (2016-12-28) | $0.045 | 23 | |
| 2017 (2017-12-27) | $0.042 | 24 | |
| 2018 (2018-12-26) | $0.057 | 22 | |
| 2019 (2019-12-25) | $0.069 | 13 | |
| 2020 (2020-12-30) | $0.073 | 11 | |
| 2021 (2021-12-29) | $0.067 | 14 | |
| 2022 (2022-12-28) | $0.068 | 11 | |
| 2023 (2023-12-27) | $0.087 | 11 | |
| 2024 (2024-12-25) | $0.063 | 15 | |
| 2025 (2025-12-31) | $0.073 | 16 | |
| 2026 (2026-11-11) | $0.074 | 16 |
Generic
$0.718 per mL at the 2013 year-end survey (4 NDCs) and $0.673 at the 2026 survey (3 NDCs): −6%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.718 | 4 | |
| 2014 (2014-12-31) | $0.653 | 4 | |
| 2015 (2015-12-30) | $0.716 | 4 | |
| 2016 (2016-12-28) | $0.670 | 4 | |
| 2017 (2017-12-27) | $0.592 | 3 | |
| 2018 (2018-12-26) | $0.556 | 3 | |
| 2019 (2019-12-25) | $0.564 | 3 | |
| 2020 (2020-12-30) | $0.595 | 3 | |
| 2021 (2021-12-29) | $0.585 | 3 | |
| 2022 (2022-12-28) | $0.525 | 3 | |
| 2023 (2023-12-27) | $0.641 | 2 | |
| 2024 (2024-12-25) | $0.635 | 3 | |
| 2025 (2025-12-31) | $0.648 | 3 | |
| 2026 (2026-11-11) | $0.673 | 3 |
Generic
$0.814 per mL at the 2013 year-end survey (4 NDCs) and $2.12 at the 2026 survey (5 NDCs): +161%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.814 | $0.740 to $0.889 | 4 |
| 2014 (2014-12-31) | $0.584 | $0.570 to $0.880 | 5 |
| 2015 (2015-12-30) | $1.46 | $0.683 to $1.46 | 3 |
| 2016 (2016-12-28) | $1.90 | $0.729 to $1.90 | 3 |
| 2017 (2017-12-27) | $0.668 | $0.657 to $0.680 | 2 |
| 2024 (2024-12-25) | $1.09 | 4 | |
| 2025 (2025-12-31) | $1.09 | 5 | |
| 2026 (2026-11-11) | $2.12 | 5 |
Generic
$0.889 per mL at the 2013 year-end survey (2 NDCs) and $0.680 at the 2017 survey (3 NDCs): −24%, a thin comparison.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.889 | 2 | |
| 2014 (2014-12-31) | $0.725 | $0.570 to $0.880 | 4 |
| 2015 (2015-12-30) | $1.46 | 2 | |
| 2016 (2016-12-28) | $1.90 | 2 | |
| 2017 (2017-12-27) | $0.680 | 3 |
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
The FDA Orange Book lists 8 generic makers as marketed in its largest dosage form for Lorazepam, and the first generic approval is dated 9 August 1985. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.
Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Lorazepam on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).